Cancer treatment: Sun Pharma to acquire Novartis' cancer drug Odomzo for $175 million

Odomzo, approved by the US FDA in July 2015, has marketing approval in over 30 countries.

from IBTimes.co.in : Science http://ift.tt/2iiU2b1